Laminitis

Uses & side effects

Laminitis

Product-specific side effects await source review.

Drug interactions

Medical management of equine laminitis is an emergency intervention focused on three primary targets: stabilizing acute foot pain, neutralizing systemic tissue damage, and addressing the underlying metabolic or endocrine causes. Because over 90% of laminitis cases stem from underlying endocrine conditions, modern veterinary protocols emphasize targeted metabolic management alongside traditional pain management.1. Acute Pain Management & Anti-InflammatoriesControlling severe orthopedic foot pain is critical to prevent the horse from overloading its other limbs and developing contralateral supporting-limb laminitis.Phenylbutazone (Bute): The historical first-line, standard non-steroidal anti-inflammatory drug (NSAID) for orthopedic lameness. While highly effective at reducing structural pain in the early phases, long-term use requires careful monitoring due to risk of gastric ulceration and right dorsal colitis.Acetaminophen (Tylenol): A valuable addition to the modern equine toolkit. Because it is cleared through the liver and does not block COX-1 enzymes, it avoids the severe gastrointestinal and renal risks associated with traditional NSAIDs. It is routinely prescribed for elderly or chronic laminitic horses, frequently acting as a synergistic component in a multi-modal pain strategy to reduce the required therapeutic dosage of classic NSAIDs.Firocoxib (Equioxx®) & Flunixin Meglumine (Banamine®): Alternative systemic NSAIDs. Flunixin is highly favored if the laminitis is secondary to an endotoxemic event, such as a severe colic or a retained placenta.Regulatory Note: Stacking multiple traditional NSAIDs (such as combining Equioxx and Banamine) is heavily penalized by governing bodies like the Equine Sports Council (ESC) and USEF due to heightened toxicity risks without increased analgesic benefits.2. Matrix Metalloproteinase (MMP) InhibitorsDuring acute laminitis, enzymes called matrix metalloproteinases (MMPs) can degrade the critical laminar connections between the hoof capsule and the coffin bone.Pentoxifylline: Prescribed during the acute developmental phase to preserve microvascular blood flow and help mitigate the enzymatic destruction of the laminae.Doxycycline: Though classified as an antibiotic, it is used off-label in acute laminitis protocols strictly for its powerful secondary ability to inhibit matrix metalloproteinases.3. Treating Underlying Endocrine ConditionsTo stop the cycle of laminitis permanently, the horse's underlying metabolic disease must be chemically controlled.Pergolide Mesylate (Prascend®): The gold-standard, FDA-approved daily medication for horses diagnosed with Pituitary Pars Intermedia Dysfunction (PPID / Cushing's disease). It stabilizes the overproduction of hormones that trigger secondary laminitic episodes.Metformin: Utilized for horses with severe, unmanaged Equine Metabolic Syndrome (EMS) and severe insulin dysregulation. It acts to curb dangerous post-meal spikes in blood glucose and circulating insulin levels.SGLT2 Inhibitors (e.g., Canagliflozin): A powerful class of medications used in refractory metabolic cases to block glucose reabsorption in the kidneys, rapidly lowering baseline insulin levels to protect the feet.Levothyroxine Sodium (Thyro-L®): A synthetic thyroid hormone supplement used short-term to jumpstart metabolism and encourage safe weight loss in dangerously obese, laminitis-prone individuals.

Contraindications